200 related articles for article (PubMed ID: 20350550)
21. Genetic approach to evaluate specificity of small molecule drug candidates inhibiting PLK1 using zebrafish.
Zhong H; Xin S; Zhao Y; Lu J; Li S; Gong J; Yang Z; Lin S
Mol Biosyst; 2010 Aug; 6(8):1463-8. PubMed ID: 20625580
[TBL] [Abstract][Full Text] [Related]
22. Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoni.
Long T; Neitz RJ; Beasley R; Kalyanaraman C; Suzuki BM; Jacobson MP; Dissous C; McKerrow JH; Drewry DH; Zuercher WJ; Singh R; Caffrey CR
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004356. PubMed ID: 26751972
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.
Liu X; Choy E; Harmon D; Yang S; Yang C; Mankin H; Hornicek FJ; Duan Z
Anticancer Drugs; 2011 Jun; 22(5):444-53. PubMed ID: 21399492
[TBL] [Abstract][Full Text] [Related]
24. Polo-like kinase-1 regulates first cleavage of one-cell embryos in culture during assisted reproduction.
Zhao Y; Ai J; Zhang H; Zhu G
Saudi Med J; 2010 Mar; 31(3):247-52. PubMed ID: 20231927
[TBL] [Abstract][Full Text] [Related]
25. On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression.
Mundt KE; Golsteyn RM; Lane HA; Nigg EA
Biochem Biophys Res Commun; 1997 Oct; 239(2):377-85. PubMed ID: 9344838
[TBL] [Abstract][Full Text] [Related]
26. Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1.
Neef R; Gruneberg U; Kopajtich R; Li X; Nigg EA; Sillje H; Barr FA
Nat Cell Biol; 2007 Apr; 9(4):436-44. PubMed ID: 17351640
[TBL] [Abstract][Full Text] [Related]
27. The Plk1 target Kizuna stabilizes mitotic centrosomes to ensure spindle bipolarity.
Oshimori N; Ohsugi M; Yamamoto T
Nat Cell Biol; 2006 Oct; 8(10):1095-101. PubMed ID: 16980960
[TBL] [Abstract][Full Text] [Related]
28. Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.
Bu Y; Yang Z; Li Q; Song F
Oncology; 2008; 74(3-4):198-206. PubMed ID: 18714168
[TBL] [Abstract][Full Text] [Related]
29. Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase.
Toyoshima-Morimoto F; Taniguchi E; Shinya N; Iwamatsu A; Nishida E
Nature; 2001 Mar; 410(6825):215-20. PubMed ID: 11242082
[TBL] [Abstract][Full Text] [Related]
30. Polo-like kinase 1 regulates mitotic arrest after UV irradiation through dephosphorylation of p53 and inducing p53 degradation.
Chen J; Dai G; Wang YQ; Wang S; Pan FY; Xue B; Zhao DH; Li CJ
FEBS Lett; 2006 Jun; 580(15):3624-30. PubMed ID: 16753148
[TBL] [Abstract][Full Text] [Related]
31. Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets.
Ding Y; Huang D; Zhang Z; Smith J; Petillo D; Looyenga BD; Feenstra K; Mackeigan JP; Furge KA; Teh BT
Cancer Res; 2011 Aug; 71(15):5225-34. PubMed ID: 21642374
[TBL] [Abstract][Full Text] [Related]
32. Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression.
Kachaner D; Filipe J; Laplantine E; Bauch A; Bennett KL; Superti-Furga G; Israël A; Weil R
Mol Cell; 2012 Feb; 45(4):553-66. PubMed ID: 22365832
[TBL] [Abstract][Full Text] [Related]
33. Schistosoma mansoni: structural and biochemical characterization of two distinct Venus Kinase Receptors.
Gouignard N; Vanderstraete M; Cailliau K; Lescuyer A; Browaeys E; Dissous C
Exp Parasitol; 2012 Sep; 132(1):32-9. PubMed ID: 21616067
[TBL] [Abstract][Full Text] [Related]
34. The polo-like kinase PLK-1 is required for nuclear envelope breakdown and the completion of meiosis in Caenorhabditis elegans.
Chase D; Serafinas C; Ashcroft N; Kosinski M; Longo D; Ferris DK; Golden A
Genesis; 2000 Jan; 26(1):26-41. PubMed ID: 10660671
[TBL] [Abstract][Full Text] [Related]
35. Systematic analysis of the Plk-mediated phosphoregulation in eukaryotes.
Liu Z; Ren J; Cao J; He J; Yao X; Jin C; Xue Y
Brief Bioinform; 2013 May; 14(3):344-60. PubMed ID: 22851512
[TBL] [Abstract][Full Text] [Related]
36. Polo-like kinases: a team in control of the division.
van de Weerdt BC; Medema RH
Cell Cycle; 2006 Apr; 5(8):853-64. PubMed ID: 16627997
[TBL] [Abstract][Full Text] [Related]
37. Polo-like kinases and the microtubule organization center: targets for cancer therapies.
Dai W; Cogswell JP
Prog Cell Cycle Res; 2003; 5():327-34. PubMed ID: 14593727
[TBL] [Abstract][Full Text] [Related]
38. Chemical genetics reveals the requirement for Polo-like kinase 1 activity in positioning RhoA and triggering cytokinesis in human cells.
Burkard ME; Randall CL; Larochelle S; Zhang C; Shokat KM; Fisher RP; Jallepalli PV
Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4383-8. PubMed ID: 17360533
[TBL] [Abstract][Full Text] [Related]
39. Evidence for Integrin - Venus Kinase Receptor 1 Alliance in the Ovary of Schistosoma mansoni Females Controlling Cell Survival.
Gelmedin V; Morel M; Hahnel S; Cailliau K; Dissous C; Grevelding CG
PLoS Pathog; 2017 Jan; 13(1):e1006147. PubMed ID: 28114363
[TBL] [Abstract][Full Text] [Related]
40. Targeting Echinococcus multilocularis stem cells by inhibition of the Polo-like kinase EmPlk1.
Schubert A; Koziol U; Cailliau K; Vanderstraete M; Dissous C; Brehm K
PLoS Negl Trop Dis; 2014 Jun; 8(6):e2870. PubMed ID: 24901228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
